Jazz Pharmaceuticals’ oral cannabidiol drug Epidiolex has disappointed in a late-phase test in Japanese children with seizures, but the company will still file there based …
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
Listen to the article 2 min This audio is auto-generated. Please let us know if you have feedback. Dive Brief: Surmodics, a maker of medical
PHILADELPHIA — An oral, non-addictive sodium channel blocker safely relieved moderate-to-severe acute pain following surgery, according to phase III data that could support regulatory approval.
Asthma patients experience respiratory distress due to allergens like house dust mites or pollen. However, the various triggers for asthma share a common pathway involving